Skip to content

Wednesday | January 14, 2026 | Dhaka

Novo Nordisk & Arogga sign MoU

Novo Nordisk Pharma Pvt. Limited and Arogga Limited have recently signed a MoU to enhance patient access to diabetes care and authentic Novo Nordisk products through digital channels in Bangladesh. From Novo Nordisk, the signing ceremony was attended by Dr. Mohammad Riad Mamun Prodhani while Co-Founder and Chief Executive Officer Rosina Mazumder represent Arogga Limited.

Business Desk :

Novo Nordisk Pharma Pvt. Limited and Arogga Limited have signed a Memorandum of Understanding (MoU) to enhance patient access to diabetes care and authentic Novo Nordisk products through digital channels in Bangladesh.

Under this partnership, Arogga will provide online ordering and home delivery of Novo Nordisk products within Dhaka, ensuring cold-chain compliance and providing QR coded instructional materials for demonstrating correct product usage.

This initiative sets a new benchmark for patient-centric innovation in Bangladesh, combining technology and accessibility while maintaining the highest compliance standards, a press release said.

From Novo Nordisk, the signing ceremony was attended by Dr. Mohammad Riad Mamun Prodhani, Managing Director and Dr. Mahbubur Rahman, Director, Clinical, Medical & Regulatory.
From Arogga Limited, Rosina Mazumder, Co-Founder and Chief Executive Officer; and Yawar Mehboob, Co-Founder & CSO were present at the event.